Caregiver-Based Fall Prevention Education in Patients Undergoing Awake Deep Brain Stimulation (CARE-DBS-FALL)
The Effect of Caregiver-Based Fall Prevention Education on Fall Prevention Behaviors and Fall Rates in Patients Undergoing Awake Deep Brain Stimulation: A Randomized Controlled Trial
Awake deep brain stimulation (DBS) is an effective surgical treatment for Parkinson's disease and other movement disorders, but patients remain at high risk of falls after surgery because of gait disturbance, postural instability, cognitive decline and transient postoperative delirium. Primary caregivers are the people in closest contact with these patients before surgery and after discharge, yet no caregiver-based fall prevention approach specific to this group has been tested. This single-center, parallel-group randomized controlled trial aims to evaluate the effect of an AI-supported structured fall prevention education given to primary caregivers before surgery on caregivers' fall prevention behaviors and on patients' postoperative falls and near-falls. Sixty-four patient-primary caregiver dyads will be randomized 1:1 to education plus usual care or usual care alone. Caregiver behaviors will be observed from postoperative day 0 to day 7 (or until discharge) using a structured observation form.
調査の概要
詳細な説明
This is a single-center, two-arm, parallel-group randomized controlled trial with a 1:1 allocation ratio, conducted at the Neurosurgery Clinic of Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. The unit of randomization is the patient-primary caregiver dyad; each patient and his/her primary caregiver are assigned to the same group, and only one primary caregiver is enrolled per patient.
Sample size was calculated with G*Power 3.1.9.7 based on a similar randomized controlled trial of caregiver fall prevention education (Wang, Zou & Wang, 2022). Because the reported effect size was large (Cohen's d = 1.14), a more conservative d = 0.80 was used with two-sided alpha = 0.05, 80% power and 1:1 allocation, giving 26 dyads per group (52 in total). Allowing for 15% attrition (dropout, change of primary caregiver, missing observations), 32 dyads per group (64 dyads; 64 patients and 64 caregivers, 128 participants) will be enrolled.
Randomization: Dyads will be allocated by computer-generated block randomization (block size 4) by an independent researcher not involved in recruitment, education or data collection. Allocation concealment will be ensured with sequentially numbered, opaque, sealed envelopes prepared by the same independent researcher; the envelope is opened after written informed consent is obtained and the Patient and Primary Caregiver Descriptive Information Form is completed.
Intervention: In addition to routine clinical care, primary caregivers in the experimental group will receive AI-supported structured fall prevention education in the preoperative period. The content, prepared according to current fall prevention literature, covers safe support during first mobilization, bed-chair transfer, walking and toileting, control of environmental risks, and safe use of assistive walking devices. Education will be delivered face to face by the same researcher, with the same content and materials, in a room separate from patient rooms to minimize contamination between groups. The control group will receive routine clinical care only; for ethical reasons, the education content will be offered to control-group caregivers after data collection is completed.
Data collection: The Patient and Primary Caregiver Descriptive Information Form (26 items) will be completed by face-to-face interview before surgery. Caregivers' fall prevention behaviors will be assessed with the Caregiver Fall Prevention Behavior Observation Form (18 behaviors in 4 sections: first mobilization, bed-chair transfer, corridor walking, assistance with toileting and return; each scored 0-2; content validity assessed by 10 experts). First mobilization is observed on postoperative day 0, and the other three sections daily on postoperative days 1-7 (or until discharge if earlier). Falls and near-falls are recorded for each section and day. Observations are performed simultaneously and independently by two trained observers; if a fall risk arises during observation, observers intervene to ensure patient safety and the event is recorded as a near-fall.
Analysis: Data will be analyzed with IBM SPSS by an independent statistician blinded to group allocation, following the intention-to-treat principle, with 95% confidence intervals and p < 0.05. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total divided by the number of observed behaviors; range 0-2) will be used, and its change over time will be analyzed with linear mixed-effects models (group, time and group-by-time interaction). Fall and near-fall counts will be analyzed with Poisson or, if needed, negative binomial regression. Inter-observer agreement will be assessed with weighted Cohen's kappa and intraclass correlation coefficient. Reporting will follow the CONSORT statement.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Kübra Can
- 電話番号:+90 543 871 17 95
- メール:kubracan@halic.edu.tr
研究場所
-
-
Basaksehir
-
Istanbul、Basaksehir、トルコ(Türkiye)、34480
- Basaksehir Cam and Sakura City Hospital, Neurosurgery Clinic
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
Patients:
- Aged 18 years or older
- Scheduled for awake deep brain stimulation surgery
- Able to communicate in Turkish
- Having a primary caregiver who will accompany the patient during the hospital stay
- Agreeing to participate in the study
Primary caregivers:
- Aged 18 years or older
- Being the patient's primary caregiver
- Taking part in the patient's care and the planned observations during the postoperative hospital stay
- Able to read and write in Turkish
- Agreeing to participate in the study
Exclusion Criteria:
Patients:
- Need for prolonged intensive care after surgery
- Development of a serious clinical complication preventing the planned mobilization and observations
- Transfer to another institution before completion of the study
- Request of the patient or legal representative to withdraw from the study
Primary caregivers:
- Not completing the structured education program (experimental group)
- Being unable to continue accompanying the patient in hospital
- Change of the primary caregiver during the study
- Request to withdraw from the study
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Caregiver Fall Prevention Education
Primary caregivers receive AI-supported structured fall prevention education, delivered face to face in the preoperative period, in addition to the clinic's routine care and information. |
Face-to-face structured education delivered by the same researcher to the primary caregiver before awake DBS surgery, using standardized AI-supported materials prepared according to current fall prevention literature. Content: safe support of the patient during first mobilization, bed-chair transfer, walking and toileting; control of environmental fall risks; and safe use of assistive walking devices. Education is given in a room separate from patient rooms. |
|
介入なし:Usual Care
Patient-caregiver dyads receive only the clinic's routine care and information. For ethical reasons, the education content will be offered to caregivers after data collection is completed. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Mean Caregiver Fall Prevention Behavior Score
時間枠:Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Measured with the Caregiver Fall Prevention Behavior Observation Form developed by the researchers (18 behaviors in 4 sections: first mobilization [5], bed-chair transfer [4], corridor walking [5], assistance with toileting and return [4]). Each behavior is scored 0 = not performed/performed incorrectly, 1 = partially correct, 2 = fully correct; behaviors not observed or not required on a given day are coded as not observed and excluded. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total score divided by the number of observed behaviors; range 0-2) is used to assess change over time; higher scores indicate more accurate and complete fall prevention behaviors. Observations are made independently by two trained observers. |
Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Number of Patient Falls During Postoperative Hospitalization
時間枠:Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Number and rate of patient falls observed during the postoperative hospital stay, recorded as yes/no for each observed activity and day on the Caregiver Fall Prevention Behavior Observation Form. |
Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
|
Number of Near-Fall Events During Postoperative Hospitalization
時間枠:Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Number and rate of near-fall events (situations in which a fall risk arose and the observers intervened to ensure patient safety) during the postoperative hospital stay. |
Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Emine Güngör Turan, MSc, Specialist Nurse、Başakşehir Çam & Sakura City Hospital
- スタディチェア:Fatma Eti Aslan, Prof. Dr.、Bahçeşehir University
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- HALIC-2026-DBS-FALL
- KAEK-326 (その他の識別子:Basaksehir Cam and Sakura City Hospital Clinical Research Ethics Committee)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared in order to protect participant confidentiality.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。